Cabaletta Bio, Inc.

CABANASDAQHealthcareBiotechnology

$1.47- (-)1Y −36.93%

As of Oct 23, 2026 close

Market cap: $222.21M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $1.39$4.23
Volume (live): -
Avg. volume (3M): 5.51M

Cabaletta Bio, Inc. (CABA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Cabaletta Bio, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(9 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$14.67

+897.96% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CABA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 21, 2026	Douglas Tsao	HC Wainwright	Reiterates	Buy	$16.00
Sep 2, 2026	Phil Nadeau	TD Cowen	Maintains	Buy	-
Sep 2, 2026	Samantha Semenkow	Citi	Maintains	Buy	$10.00
Sep 1, 2026	Unknown Analyst	Wells Fargo	Reiterates	Hold	$3.00
Aug 17, 2026	Michael Ulz	Morgan Stanley	Reiterates	Buy	$13.00
Aug 14, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$16.00
Aug 14, 2026	Joshua Schimmer	Cantor Fitzgerald	Reiterates	Buy	$30.00
Aug 13, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$16.00
Aug 13, 2026	Sami Corwin	William Blair	Maintains	Buy	-

Douglas Tsao

HC Wainwright

BuyReiterates

$16.00

Sep 21

Phil Nadeau

TD Cowen

BuyMaintains

Sep 2

Samantha Semenkow

Citi

BuyMaintains

$10.00

Sep 2

Unknown Analyst

Wells Fargo

HoldReiterates

$3.00

Sep 1

Michael Ulz

Morgan Stanley

BuyReiterates

$13.00

Aug 17

Yatin Suneja

Guggenheim

BuyReiterates

$16.00

Aug 14

Joshua Schimmer

Cantor Fitzgerald

BuyReiterates

$30.00

Aug 14

Yatin Suneja

Guggenheim

BuyReiterates

$16.00

Aug 13

Sami Corwin

William Blair

BuyMaintains

Aug 13

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CABA?

The analyst consensus rating for CABA is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for CABA?

The average 12-month price target for CABA is $14.67, representing an upside of 898.0% from the Oct 23, 2026 close of $1.47.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.